Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by BayStreetWildon May 12, 2023 8:35pm
268 Views
Post# 35446560

You keep buying em…

You keep buying em…

They'll keep makin em..

the old ones that are still yet to expire because milestones weren't hit haven't even expired and new ones are being rolled out. Hahahaha this company is something else. Talk about a lifestyle.


Are you serious??? $901k a year... hahahahahahahahahahahahahahahahah

egregious does not even begin to describe it... who is this guy? Albert Bourla
 

Subsequent Event
On May 5, 2023 the Board of Directors approved the following grants pursuant to the Company’s LTIP: i) 1,372,549 DSUs issued to the Board of Directors;
ii) 2,772,828 Stock Options and 2,072,424 RSUs issued to the Company’s CEO, CMO and CFO; and iii) 250,000 Stock Options issued to certain consultants of the Company.
<< Previous
Bullboard Posts
Next >>